Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease

► Psychotropics are widely used in treating Parkinson's disease (PD). ► Initial evidence indicates these psychotropics can affect PD risk-gene transcription. ► Further study of PD risk-gene transcription in PD clinical models is warranted. ► Studies should focus on psychotropic-related modification of PD risk and progression.